We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

H:NYSEHyatt Hotels Corporation Analysis

Data as of 2026-04-07 - not real-time

$145.99

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Hyatt Hotels (H) trades at $145.99, just above its 20‑day SMA (145.34) but still below the 50‑day (155.69) and 200‑day (150.92) averages, indicating a neutral to slightly bearish price bias. The RSI of 46 reinforces a lack of momentum, while the MACD histogram (+0.62) suggests a modest bullish crossover. However, the stock carries a high beta of 1.31 and a 30‑day volatility of 47%, exposing it to amplified market swings. Fundamentally, Hyatt reports a negative profit margin (‑1.5%) and a trailing EPS of –$0.55, yet it maintains a modest dividend yield of 0.42% with a low payout ratio, raising questions about long‑term sustainability. The balance sheet is heavily leveraged, with a debt‑to‑equity ratio of 124% and total debt exceeding $4.5 B, far outweighing its $0.8 B cash position. A discounted cash flow model values the company at roughly $76 per share, implying the current price is significantly overvalued.
Recent news adds a mixed backdrop: a prestigious award for the Grand Hyatt at SFO and a strategic push into lifestyle brands provide upside catalysts, while a leadership transition and a legal probe into directors introduce near‑term uncertainty. Investors should weigh the growth narrative against the steep valuation gap, high leverage, and elevated volatility before deciding on positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term support with limited upside
  • Legal investigation adds downside risk
  • High volatility and beta amplify market moves

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic expansion of lifestyle brands could drive revenue growth
  • Award‑winning property enhances brand perception
  • Improving operating cash flow may support debt reduction

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Heavy debt load limits financial flexibility
  • Negative earnings and thin margins raise sustainability concerns
  • Valuation gap suggests limited upside unless fundamentals turn around

Key Metrics & Analysis

Financial Health

Revenue Growth17.50%
Profit Margin-1.50%
P/E Ratio31.7
ROE-1.31%
ROA2.38%
Debt/Equity124.52
P/B Ratio4.1
Op. Cash Flow$379.0M
Free Cash Flow$394.5M

Technical Analysis

TrendNeutral
RSI46.1
Support$137.53
Resistance$157.36
MA 20$145.34
MA 50$155.69
MA 200$150.92
MACDBullish
VolumeDecreasing
Fear & Greed Index77.57

Valuation

Fair Value$75.93
Target Price$182.79
Upside/Downside25.21%
GradeOvervalued
TypeGrowth
Dividend Yield0.42%

Risk Assessment

Beta1.31
Volatility46.98%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.